Evidence map›Paper›PMID 32747765›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Application of exome sequencing for prenatal diagnosis: a rapid scoping review.

Misty Pratt, Chantelle Garritty, Micere Thuku, Leila Esmaeilisaraji, Candyce Hamel, Taila Hartley, Kathryn Millar, Becky Skidmore, Shelley Dougan, Christine M Armour

Open access · bronzeAbstract readScoping Review
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Genetics in prenatal diagnosis.Singapore medical journal · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Misty PrattChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada. prattmisty@hotmail.com.ORCID http://orcid.org/0000-0001-9247-9036
Chantelle GarrittyKnowledge Synthesis Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Micere ThukuKnowledge Synthesis Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Leila EsmaeilisarajiKnowledge Synthesis Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Candyce HamelKnowledge Synthesis Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Taila HartleyChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Kathryn MillarBetter Outcomes Registry Network (BORN) Ontario, Ottawa, ON, Canada.
Becky SkidmoreIndependent consultant, Ottawa, ON, Canada.
Shelley DouganBetter Outcomes Registry Network (BORN) Ontario, Ottawa, ON, Canada.
Christine M ArmourChildren's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Ottawa Hospital · CAChildren's Hospital of Eastern Ontario · CAOntario Stroke Network · CACongress of Aboriginal Peoples · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic diagnosis provides important information for prenatal decision-making and management. Promising results from exome sequencing (ES) for genetic diagnosis in fetuses with structural anomalies are emerging. The objective of this scoping review was to identify what is known about the use of ES for genetic testing in prenatal cases with known or suspected genetic disease. A rapid scoping review was conducted over a six-week timeframe of English-language peer-reviewed studies. Search strategies for major databases (e.g., Medline) and gray literature were developed, and peer reviewed by information specialists. Identified studies were categorized and charted using tables and diagrams. Twenty-four publications were included from seven countries published between 2014 and 2019. Most commonly reported outcomes were diagnostic yields, which varied widely from 5% to 57%, and prenatal phenotype. Few studies reported clinical outcomes related to impact, decision-making, and clinical utility. Qualitative studies (n = 6) provided useful insights into patient and health-care provider experiences with ES. Findings suggest prenatal ES is beneficial, but more research is needed to better understand the clinical utility, circumstances for ideal use, feasibility, and costs of offering rapid ES as a routine option for prenatal genetic testing.

Indexed as

ExomeGenetic TestingExome SequencingFemaleFetusHumansPhenotypePregnancyPrenatal Diagnosiscongenital anomaliesexome sequencingprenatal genetic diagnosisscoping reviewsystematic review

Identifiers

PMID32747765
OpenAlexW3047156590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.